본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Cancer risk according to fasting blood glucose trajectories: A population-based cohort study Oh J K
(Department of Clinical Nursing Science)

Thu Thi Minh KHONG
(Department of Cancer Biomedical Science)
. Cancer risk according to fasting blood glucose trajectories: A population-based cohort study. BMJ Open Diabetes Research & Care. 2024-02-27; 2024; 12(1):e003696~. IF 3.7 (2023)
Factors related to tumor response rate from TCGA three omics data-variants, expression, methylation
()

Ahn Hyung-Min
(Center for Lung Cancer)
. Factors related to tumor response rate from TCGA three omics data-variants, expression, methylation. Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis. 2024-02-26; 2024; 42(3):173~188. IF 1.2 (2023)
Correspondence on Editorial regarding Lee Yeon Su
(Rare & Pediatric Cancer Branch)


()
. Correspondence on Editorial regarding "Identification of signature gene set as highly accurate determination of MASLD progression". Clinical and Molecular Hepatology. 2024-02-23; 2024; 30(2):287~290. IF 14 (2023)
The interaction between magnesium intake, the genetic variant INSR rs1799817 and colorectal cancer risk in a Korean population: a case-control study Kim Jeong seon
(Department of Cancer AI and Digital Health)


(Department of Cancer Biomedical Science)
. The interaction between magnesium intake, the genetic variant INSR rs1799817 and colorectal cancer risk in a Korean population: a case-control study. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION. 2024-02-22; 2024; 75(4):396~406. IF 3.5 (2023)
Factors affecting accuracy of clinical staging in resectable non-smal cell lung cancer in a real-world study
()

Gwon Hye Ran
(Branch of Pulmonology)
. Factors affecting accuracy of clinical staging in resectable non-smal cell lung cancer in a real-world study. THORACIC CANCER. 2024-02-21; 2024; 15(9):730~737. IF 2.3 (2023)
Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as a MASLD progression markers Lee Yeon Su
(Rare & Pediatric Cancer Branch)


()
. Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as a MASLD progression markers. HEPATOLOGY. 2024-02-20; 2024; 81(3):962~975. IF 13 (2023)
Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy: A Retrospective Observational Study Gwak Ho Shin
(Department of Neurosurgery)

Kim Ki Hoon
(Department of Neurology)
. Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy: A Retrospective Observational Study. NEUROLOGY. 2024-02-16; 2024; 102(5):e209167~. IF 8.4 (2023)
The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation Kang EunKyo
(Division of Cancer Screening and Early Detection)


()
. The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation. TOBACCO INDUCED DISEASES. 2024-02-14; 2024; 22:37~. IF 2.2 (2023)
A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules
()

Lee Eun Kyung
(Targeted Therapy Branch)
. A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules. Endocrinology and Metabolism. 2024-02-14; 2024; 39(1):61~72. IF 3.9 (2023)
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy Han Ji-Youn
(Anticancer Resistance Branch )

Kim, Sun Shin
(Targeted Therapy Branch)
. Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers. 2024-02-14; 2024; 16(4):778~. IF 4.5 (2023)
First page Prev paging 41 42 43 44 45 46 47 48 49 50 next paging last page